{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T21:51:41Z","timestamp":1774907501614,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s10549-023-07027-6","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T09:02:06Z","timestamp":1688720526000},"page":"489-498","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Treatments for breast cancer in men: late effects and impact on quality of life"],"prefix":"10.1007","volume":"201","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8973-5166","authenticated-orcid":false,"given":"Jorge","family":"Avila","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Herrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deanna J.","family":"Attai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Pablo","family":"Leone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,7]]},"reference":[{"issue":"24","key":"7027_CR1","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1056\/NEJMra1707939","volume":"378","author":"SH Giordano","year":"2018","unstructured":"Giordano SH (2018) Breast cancer in men. N Engl J Med 378(24):2311\u20132320. https:\/\/doi.org\/10.1056\/NEJMra1707939","journal-title":"N Engl J Med"},{"issue":"1","key":"7027_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA: A Cancer Jr Clinic 73(1):17\u201348. https:\/\/doi.org\/10.3322\/caac.21763","journal-title":"CA: A Cancer Jr Clinic"},{"key":"7027_CR3","unstructured":"Key Statistics for Breast Cancer in Men. (2022) https:\/\/www.cancer.org\/cancer\/breast-cancer-in-men\/about\/key-statistics.html. Accessed 17 Aug 2022\\"},{"issue":"8","key":"7027_CR4","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1002\/ijc.27841","volume":"132","author":"D Ly","year":"2013","unstructured":"Ly D, Forman D, Ferlay J, Brinton LA, Cook MB (2013) An international comparison of male and female breast cancer incidence rates. Int J Cancer 132(8):1918\u20131926. https:\/\/doi.org\/10.1002\/ijc.27841","journal-title":"Int J Cancer"},{"key":"7027_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.breast.2020.08.010","volume":"54","author":"S Konduri","year":"2020","unstructured":"Konduri S, Singh M, Bobustuc G, Rovin R, Kassam A (2020) Epidemiology of male breast cancer. Breast 54:8\u201314. https:\/\/doi.org\/10.1016\/j.breast.2020.08.010","journal-title":"Breast"},{"issue":"23","key":"7027_CR6","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/jnci\/djm203","volume":"99","author":"YC Tai","year":"2007","unstructured":"Tai YC, Domchek S, Parmigiani G, Chen S (2007) Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 99(23):1811\u20131814. https:\/\/doi.org\/10.1093\/jnci\/djm203","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"7027_CR7","doi-asserted-by":"publisher","first-page":"e990","DOI":"10.1634\/theoncologist.2019-0871","volume":"25","author":"KL Corrigan","year":"2020","unstructured":"Corrigan KL, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF et al (2020) Exclusion of men from randomized phase III breast cancer clinical trials. Oncologist 25(6):e990\u2013e992. https:\/\/doi.org\/10.1634\/theoncologist.2019-0871","journal-title":"Oncologist"},{"issue":"8","key":"7027_CR8","doi-asserted-by":"publisher","first-page":"678","DOI":"10.7326\/0003-4819-137-8-200210150-00013","volume":"137","author":"SH Giordano","year":"2002","unstructured":"Giordano SH, Buzdar AU, Hortobagyi GN (2002) Breast cancer in men. Ann Intern Med 137(8):678\u2013687. https:\/\/doi.org\/10.7326\/0003-4819-137-8-200210150-00013","journal-title":"Ann Intern Med"},{"issue":"2","key":"7027_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/annonc\/mdx651","volume":"29","author":"F Cardoso","year":"2018","unstructured":"Cardoso F, Bartlett JMS, Slaets L, van Deurzen CHM, van Leeuwen-Stok E, Porter P et al (2018) Characterization of male breast cancer: results of the EORTC 10085\/TBCRC\/BIG\/NABCG international male breast cancer program. Ann Oncol 29(2):405\u2013417. https:\/\/doi.org\/10.1093\/annonc\/mdx651","journal-title":"Ann Oncol"},{"issue":"6","key":"7027_CR10","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1093\/annonc\/mdr459","volume":"23","author":"N Pemmaraju","year":"2012","unstructured":"Pemmaraju N, Munsell MF, Hortobagyi GN, Giordano SH (2012) Retrospective review of male breast cancer patients: analysis of tamoxifen-related side-effects. Ann Oncol 23(6):1471\u20131474. https:\/\/doi.org\/10.1093\/annonc\/mdr459","journal-title":"Ann Oncol"},{"issue":"1","key":"7027_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10549-011-1649-1","volume":"130","author":"AS Reiner","year":"2011","unstructured":"Reiner AS, Jacks LM, Van Zee KJ, Panageas KS (2011) A SEER-Medicare population-based study of lymphedema-related claims incidence following breast cancer in men. Breast Cancer Res Treat 130(1):301\u2013306. https:\/\/doi.org\/10.1007\/s10549-011-1649-1","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"7027_CR12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10549-016-4085-4","volume":"161","author":"M Pritzlaff","year":"2017","unstructured":"Pritzlaff M, Summerour P, McFarland R, Li S, Reineke P, Dolinsky JS et al (2017) Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results. Breast Cancer Res Treat 161(3):575\u2013586. https:\/\/doi.org\/10.1007\/s10549-016-4085-4","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"7027_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13045-020-01010-0","volume":"14","author":"Y Liu","year":"2021","unstructured":"Liu Y, Wang H, Wang X, Liu J, Li J, Wang X et al (2021) Prevalence and reclassification of BRCA1 and BRCA2 variants in a large, unselected Chinese Han breast cancer cohort. J Hematol Oncol 14(1):18. https:\/\/doi.org\/10.1186\/s13045-020-01010-0","journal-title":"J Hematol Oncol"},{"issue":"1","key":"7027_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13058-016-0700-x","volume":"18","author":"A Hinzey","year":"2016","unstructured":"Hinzey A, Gaudier-Diaz MM, Lustberg MB, DeVries AC (2016) Breast cancer and social environment: getting by with a little help from our friends. Breast Cancer Res 18(1):54. https:\/\/doi.org\/10.1186\/s13058-016-0700-x","journal-title":"Breast Cancer Res"},{"issue":"4","key":"7027_CR15","doi-asserted-by":"publisher","first-page":"e0231691","DOI":"10.1371\/journal.pone.0231691","volume":"15","author":"A Adam","year":"2020","unstructured":"Adam A, Koranteng F (2020) Availability, accessibility, and impact of social support on breast cancer treatment among breast cancer patients\u00a0in Kumasi, Ghana: a qualitative study. PLoS One 15(4):e0231691. https:\/\/doi.org\/10.1371\/journal.pone.0231691","journal-title":"PLoS One"},{"key":"7027_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.breast.2017.06.017","volume":"35","author":"M Salakari","year":"2017","unstructured":"Salakari M, Pylkk\u00e4nen L, Sillanm\u00e4ki L, Nurminen R, Rautava P, Koskenvuo M et al (2017) Social support and breast cancer: a comparatory study of breast cancer survivors, women with mental depression, women with hypertension and healthy female controls. Breast 35:85\u201390. https:\/\/doi.org\/10.1016\/j.breast.2017.06.017","journal-title":"Breast"},{"issue":"6","key":"7027_CR17","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s10508-015-0530-4","volume":"44","author":"IG Motofei","year":"2015","unstructured":"Motofei IG, Rowland DL, Popa F, Bratucu E, Straja D, Manea M et al (2015) A pilot study on tamoxifen sexual side effects and hand preference in male breast cancer. Arch Sex Behav 44(6):1589\u20131594. https:\/\/doi.org\/10.1007\/s10508-015-0530-4","journal-title":"Arch Sex Behav"},{"issue":"1","key":"7027_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/1097-0142(19940701)74:1<74::aid-cncr2820740113>3.0.co;2-#","volume":"74","author":"TF Anelli","year":"1994","unstructured":"Anelli TF, Anelli A, Tran KN, Lebwohl DE, Borgen PI (1994) Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients. Cancer 74(1):74\u201377. https:\/\/doi.org\/10.1002\/1097-0142(19940701)74:1%3c74::aid-cncr2820740113%3e3.0.co;2-#","journal-title":"Cancer"},{"issue":"1","key":"7027_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11764-020-00908-5","volume":"15","author":"MJ Berkowitz","year":"2021","unstructured":"Berkowitz MJ, Thompson CK, Zibecchi LT, Lee MK, Streja E, Berkowitz JS et al (2021) How patients experience endocrine therapy for breast cancer: an online survey of side effects, adherence, and medical team support. J Cancer Surviv 15(1):29\u201339. https:\/\/doi.org\/10.1007\/s11764-020-00908-5","journal-title":"J Cancer Surviv"},{"issue":"3","key":"7027_CR20","first-page":"1439","volume":"10","author":"O Usta","year":"2017","unstructured":"Usta O, Gokcol D (2017) Sexual dysfunction in women with breast cancer receiving chemotherapy. Int J Caring Sci 10(3):1439\u20131446","journal-title":"Int J Caring Sci"},{"issue":"2","key":"7027_CR21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3109\/0284186X.2010.533190","volume":"50","author":"M Ewertz","year":"2011","unstructured":"Ewertz M, Jensen AB (2011) Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncol 50(2):187\u2013193. https:\/\/doi.org\/10.3109\/0284186X.2010.533190","journal-title":"Acta Oncol"},{"issue":"1","key":"7027_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/NCC.0000000000000745","volume":"44","author":"D Trusson","year":"2021","unstructured":"Trusson D, Quincey K (2021) Breast cancer and hair loss: experiential similarities and differences in men\u2019s and women\u2019s narratives. Cancer Nurs 44(1):62\u201370. https:\/\/doi.org\/10.1097\/NCC.0000000000000745","journal-title":"Cancer Nurs"},{"issue":"1","key":"7027_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s41687-020-00187-9","volume":"4","author":"K Biering","year":"2020","unstructured":"Biering K, Frydenberg M, Pappot H, Hjollund NH (2020) The long-term course of fatigue following breast cancer diagnosis. J Patient Rep Outcomes 4(1):37. https:\/\/doi.org\/10.1186\/s41687-020-00187-9","journal-title":"J Patient Rep Outcomes"},{"issue":"6","key":"7027_CR24","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/annonc\/mdw099","volume":"27","author":"HJG Abrahams","year":"2016","unstructured":"Abrahams HJG, Gielissen MFM, Schmits IC, Verhagen CAHHVM, Rovers MM, Knoop H (2016) Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: a meta-analysis involving 12 327 breast cancer survivors. Ann Oncol 27(6):965\u201374. https:\/\/doi.org\/10.1093\/annonc\/mdw099","journal-title":"Ann Oncol"},{"key":"7027_CR25","doi-asserted-by":"publisher","first-page":"556718","DOI":"10.3389\/fonc.2020.556718","volume":"10","author":"M Invernizzi","year":"2020","unstructured":"Invernizzi M, de Sire A, Lippi L, Venetis K, Sajjadi E, Gimigliano F et al (2020) Impact of rehabilitation on breast cancer related fatigue: a pilot study. Front Oncol 10:556718. https:\/\/doi.org\/10.3389\/fonc.2020.556718","journal-title":"Front Oncol"},{"key":"7027_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx162","author":"H Bandos","year":"2018","unstructured":"Bandos H, Melnikow J, Rivera DR, Swain SM, Sturtz K, Fehrenbacher L et al (2018) Long-term peripheral neuropathy in breast cancer patients treated with adjuvant chemotherapy: NRG oncology\/NSABP B-30. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djx162","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"7027_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1200\/jco.2006.10.064","volume":"24","author":"K Brain","year":"2006","unstructured":"Brain K, Williams B, Iredale R, France L, Gray J (2006) Psychological distress in men with breast cancer. J Clin Oncol 24(1):95\u2013101. https:\/\/doi.org\/10.1200\/jco.2006.10.064","journal-title":"J Clin Oncol"},{"issue":"1","key":"7027_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s43045-020-00036-x","volume":"27","author":"HA Alagizy","year":"2020","unstructured":"Alagizy HA, Soltan MR, Soliman SS, Hegazy NN, Gohar SF (2020) Anxiety, depression and perceived stress among breast cancer patients: single institute experience. Middle East Current Psychiatry 27(1):29. https:\/\/doi.org\/10.1186\/s43045-020-00036-x","journal-title":"Middle East Current Psychiatry"},{"key":"7027_CR29","unstructured":"Administration USDoHaHSFaD. Male Breast Cancer: Developing Drugs for Treatment Guidance for Industry. In: Administration FaD, editor.2020."},{"issue":"1","key":"7027_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000358751","volume":"9","author":"M Kipling","year":"2014","unstructured":"Kipling M, Ralph JE, Callanan K (2014) Psychological impact of male breast disorders: literature review and survey results. Breast Care (Basel) 9(1):29\u201333. https:\/\/doi.org\/10.1159\/000358751","journal-title":"Breast Care (Basel)"},{"issue":"1","key":"7027_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000501956","volume":"15","author":"SM Halbach","year":"2020","unstructured":"Halbach SM, Midding E, Ernstmann N, W\u00fcrstlein R, Weber R, Christmann S et al (2020) Male breast cancer patients\u2019 perspectives on their health care situation: a mixed-methods study. Breast Care (Basel) 15(1):22\u201329. https:\/\/doi.org\/10.1159\/000501956","journal-title":"Breast Care (Basel)"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-07027-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-023-07027-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-07027-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T12:15:06Z","timestamp":1693138506000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-023-07027-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,7]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["7027"],"URL":"https:\/\/doi.org\/10.1007\/s10549-023-07027-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,7]]},"assertion":[{"value":"30 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JPL has research funding from Kazia therapeutics and consulting from Minerva Therapeutics. All other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study received approval from the Institutional Review Board of St. Elizabeth\u2019s Medical Center.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This study received approval from the Institutional Review Board of St. Elizabeth\u2019s Medical Center.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Informed consent was obtained by the participants. The introductory page of the survey indicated that \u201cBy completing this survey, you are consenting to participate in this study and attesting that you are 18 or older.\u201d","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Publish to consent was obtained from the participants. The introductory page of the survey indicated that \u201cthe final results will be presented in scientific research meetings or published in a medical journal.\u201d","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}